Stakeholder perspectives on the impact of COVID-19 on oncology services: a qualitative study.
COVID-19
Cancer
Health service change
Oncology
Qualitative
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
24 Jul 2023
24 Jul 2023
Historique:
received:
24
02
2023
accepted:
28
06
2023
medline:
26
7
2023
pubmed:
25
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
As COVID-19 spread across the globe, cancer services were required to rapidly pivot to minimise risks without compromising outcomes for patients or staff. The aim of this study was to document changes to oncology services as a result of COVID-19 from the perspectives of both providers and receivers of care during the initial phase of the pandemic. Participants were recruited between June and December 2020 through an email invitation via professional or consumer organisations, two hospital-based oncology services and snowballing. Semi-structured interviews focused on health service changes and their impacts, which were then analysed by thematic analysis. Thirty-two patients, 16 carers and 29 health professionals were recruited. Fifteen patients (n = 47%) had localised disease, and 19 (n = 59%) were currently receiving treatment. Oncology staff included oncologists, palliative care physicians, nurses, allied health and psychosocial practitioners. Four themes arose from the data: safety, increased stress and burnout, communication challenges and quality of cancer care. There is an ongoing need for cancer-specific information from a single, trusted source to inform medical practitioners and patients/carers. More data are required to inform evidence-based guidelines for cancer care during future pandemics. All stakeholders require ongoing support to avoid stress and burnout.
Sections du résumé
BACKGROUND
BACKGROUND
As COVID-19 spread across the globe, cancer services were required to rapidly pivot to minimise risks without compromising outcomes for patients or staff. The aim of this study was to document changes to oncology services as a result of COVID-19 from the perspectives of both providers and receivers of care during the initial phase of the pandemic.
METHODS
METHODS
Participants were recruited between June and December 2020 through an email invitation via professional or consumer organisations, two hospital-based oncology services and snowballing. Semi-structured interviews focused on health service changes and their impacts, which were then analysed by thematic analysis.
RESULTS
RESULTS
Thirty-two patients, 16 carers and 29 health professionals were recruited. Fifteen patients (n = 47%) had localised disease, and 19 (n = 59%) were currently receiving treatment. Oncology staff included oncologists, palliative care physicians, nurses, allied health and psychosocial practitioners. Four themes arose from the data: safety, increased stress and burnout, communication challenges and quality of cancer care.
CONCLUSIONS
CONCLUSIONS
There is an ongoing need for cancer-specific information from a single, trusted source to inform medical practitioners and patients/carers. More data are required to inform evidence-based guidelines for cancer care during future pandemics. All stakeholders require ongoing support to avoid stress and burnout.
Identifiants
pubmed: 37488459
doi: 10.1007/s00520-023-07916-y
pii: 10.1007/s00520-023-07916-y
pmc: PMC10366245
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
491Informations de copyright
© 2023. The Author(s).
Références
J Psychosoc Oncol. 2021;39(3):479-484
pubmed: 33787464
BMJ Support Palliat Care. 2020 Dec 21;:
pubmed: 33355162
Patient Educ Couns. 2022 Jul;105(7):2397-2403
pubmed: 35120797
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Support Care Cancer. 2021 Sep;29(9):5463-5473
pubmed: 33694089
Future Oncol. 2020 Oct;16(29):2283-2293
pubmed: 32677462
JCO Glob Oncol. 2021 Feb;7:311-323
pubmed: 33617304
N Engl J Med. 2020 Jun 11;382(24):e88
pubmed: 32289215
JCO Oncol Pract. 2021 Jul;17(7):e427-e438
pubmed: 34152789
Int J Nurs Stud Adv. 2021 Nov;3:100030
pubmed: 34075361
J Psychosoc Oncol. 2021;39(3):428-444
pubmed: 33886433
JCO Oncol Pract. 2021 Sep;17(9):546-564
pubmed: 34319760
Clin Cancer Res. 2020 Nov 15;26(22):5809-5813
pubmed: 32816894
EClinicalMedicine. 2020 Nov 30;29-30:100656
pubmed: 33437952
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Lancet Reg Health West Pac. 2021 Sep;14:100226
pubmed: 34368796